| pegylated liposomal doxorubicin / Generic mfg. |
NCT00097019: A Study of Bevacizumab in Ovarian Cancer or Primary Peritoneal Cancer Where Doxil or Topotecan Therapy Has Failed |
|
|
| Completed | 2 | 53 | NA | bevacizumab | Genentech, Inc. | Ovarian Cancer | 05/06 | 05/06 | | |
NCT00312650: Doxil and Gemcitabine in Recurrent Ovarian Cancer |
|
|
| Terminated | 2 | 24 | US | liposomal doxorubicin and gemcitabine | Women and Infants Hospital of Rhode Island, Ortho Biotech, Inc. | Ovarian Carcinoma | 05/06 | 05/06 | | |
NCT00216645: Phase II Clinical Study of Pegylated Liposomal Doxorubicin Hydrochloride Injection as 2nd-line or Later Therapy in Patients With Mullerian Carcinoma (Epithelial Ovarian Carcinoma, Primary Carcinoma of Fallopian Tube, Peritoneal Carcinoma) Having Prior Platinum-Based Chemotherapy |
|
|
| Completed | 2 | 74 | Japan | doxorubicin hydrochloride | Janssen Pharmaceutical K.K. | Ovarian Neoplasms | | 11/06 | | |
NCT00780039: A Study to Evaluate the Safety and Efficacy of Caelyx in Combination With Carboplatin in Patients With Ovarian Cancer Recurrent Within Six to Twelve Months After Initial Carboplatin and Paclitaxel Chemotherapy (P03625) |
|
|
| Completed | 2 | 58 | NA | Pegylated Liposomal Doxorubicin, SCH 200746, Carboplatin | Merck Sharp & Dohme LLC, Princess Margaret Hospital, Canada | Ovarian Neoplasms | 09/07 | 09/07 | | |
NCT00003896: S9912 Combination Chemo in Stage III Ovarian Cancer, |
|
|
| Completed | 2 | 68 | US | cisplatin, platinol, liposomal doxorubicin, pegylated liposomal doxorubicin hydrochloride, doxil, paclitaxel, taxol | Southwest Oncology Group, National Cancer Institute (NCI) | Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer | 02/08 | 02/08 | | |
NCT00653328: Ph II Atrasentan + DOXIL in Recurrent Ovarian/Fallopian/Peritoneal Serous Papillary Adenocarcinoma |
|
|
| Terminated | 2 | 15 | US | atrasentan hydrochloride, ABT-627, Xinlay, doxil, pegylated liposomal doxorubicin hydrochloride (Doxil) | Vanderbilt-Ingram Cancer Center, National Cancer Institute (NCI) | Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer | 03/09 | 03/09 | | |
NCT00758732: Docetaxel/Carboplatin Versus Docetaxel/Caelyx in Pretreated Patients With Ovarian Carcinoma |
|
|
| Terminated | 2 | 34 | Europe | Docetaxel, Taxotere, Carboplatin, Liposomal doxorubicin, Caelyx | Hellenic Oncology Research Group, University Hospital of Crete | Ovarian Cancer | 03/11 | 03/11 | | |
| Completed | 2 | 33 | Europe | Pegylated liposomal doxorubicin, Caelyx, Panitumumab, Vectibix | Vejle Hospital | Epithelial Ovarian Cancer | 08/11 | 08/12 | | |
|
|
NCT01991210 / 2012-005776-34: A Study of DNIB0600A in Comparison With Pegylated Liposomal Doxorubicin (PLD) in Participants With Platinum-Resistant Ovarian Cancer (PROC) |
|
|
| Terminated | 2 | 95 | US, Canada, Europe | DNIB0600A, RO5541081, PLD | Genentech, Inc. | Ovarian Cancer | 08/16 | 08/16 | | |
|
NCT00237627: Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer |
|
|
| Completed | 1/2 | 107 | US | PS-341, Doxil, pegylated liposomal doxorubicin, Velcade, Bortezomib | UNC Lineberger Comprehensive Cancer Center, National Cancer Institute (NCI) | Breast Cancer, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Ovarian Cancer, Unspecified Adult Solid Tumor, Protocol Specific | 12/06 | 01/10 | | |
NCT00562185: Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian Cancer |
|
|
| Withdrawn | 1/2 | 0 | US | carboplatin, doxorubicin hydrochloride | University of Texas Southwestern Medical Center, Ortho Biotech Clinical Affairs, L.L.C. | Ovarian Cancer | 03/09 | 03/09 | | |
NCT00903630: Lenalidomide and Doxorubicin Hydrochloride Liposome in Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer |
|
|
| Terminated | 1/2 | 15 | US | Lenalidomide, Revlimid, liposomal doxorubicin, Caelyx® | Masonic Cancer Center, University of Minnesota, Celgene Corporation | Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer | 08/11 | 08/11 | | |
NCT00182767: Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian Cancer |
|
|
| Completed | 1/2 | 45 | US | ixabepilone, BMS-247550, epothilone B lactam, Ixempra, pegylated liposomal doxorubicin hydrochloride, CAELYX, Dox-SL, DOXIL, doxorubicin hydrochloride liposome, LipoDox | National Cancer Institute (NCI) | Fallopian Tube Cancer, Female Reproductive Cancer, Recurrent Breast Cancer, Recurrent Ovarian Epithelial Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Breast Cancer, Stage IV Ovarian Epithelial Cancer | 04/12 | 05/14 | | |
